New York-based researchers from the Icahn School of Medicine at Mount Sinai have introduced KiNet, an interactive web portal designed to explore kinase-substrate interactions in human cellular systems. The portal, which aggregates data from multiple public databases, aims to provide the scientific community with a comprehensive platform for visualising and studying these interactions in systemwide […]
The Jackson Laboratory (JAX) in Maine, USA, has received a $1.6 million grant from the National Institutes of Health (NIH) to acquire a state-of-the-art mass spectrometry system. This new equipment, the Bruker timsTOF Ultra2, will significantly enhance the institution’s ability to conduct detailed analyses of proteins and metabolites at the single-cell level.
The FinnGen project, a large-scale Finnish research initiative in personalised medicine, has announced a collaboration with Azenta, Inc. to provide proteomics profiling for up to 20,000 individuals. This partnership aims to integrate proteomic insights with existing genomic data, with the aim advancing our understanding of complex diseases and paving the way for more targeted treatments.
Exothera, a GMP-certified contract development and manufacturing organisation (CDMO) specialising in viral vectors, RNA therapeutics, and vaccines, has announced the appointment of Cédric Volanti as its new Chief Executive Officer. The appointment, effective 8 October 2024, marks a significant milestone for the Belgian company as it seeks to strengthen its position in the biopharmaceutical manufacturing […]
Fujifilm Irvine Scientific, a provider of cell culture solutions for life science and medical markets, has announced an expansion of its product portfolio through alignment with its sister company, Fujifilm Wako Chemicals U.S.A., Corp. From 1 October 2024, Fujifilm Irvine Scientific will directly promote products from three divisions of Fujifilm Wako Chemicals –Lab Automation, Lab […]
Beckman Coulter, a prominent clinical diagnostics company, and Scopio Labs, a MedTech firm specialising in digital cell morphology solutions, have announced an expansion of their long-term partnership. The new agreement includes global distribution of Scopio’s Full-Field Bone Marrow Aspirate™ (FF-BMA) Application, which is CE-Marked for use with Scopio’s X100 and X100HT scanners.
Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, today jointly announced expansion of its long-term partnership to include a global distribution agreement of Scopio’s Full-Field Bone Marrow Aspirate™ (FF-BMA) Application. Scopio’s X100 / X100HT with FF-BMA Application are CE-Marked.
Eli Lilly and Company has announced plans for a $4.5 billion (£3.6 billion) facility that integrates pharmaceutical research and manufacturing. The Lilly Medicine Foundry, revealed on 2 October 2024, will aim to streamline drug discovery and production processes. This approach could significantly accelerate the journey from drug development through clinical trials to manufacturing.
The Intelligent Analyzer
AltoStar® Molecular Diagnostic Workflow
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.